FDA recall D-0177-2025 · initiated Dec 12, 2024
Most serious — a reasonable probability that use will cause serious harm or death.
Marketed without an Approved NDA/ANDA: FDA analysis found the products to be tainted with undeclared Furosemide, Dexamethasone and Chlorpheniramine